Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Randox Biochip Array Technology is the Leading Methodology for Drug Detection in Oral Fluid

Published: Tuesday, December 27, 2011
Last Updated: Tuesday, December 27, 2011
Bookmark and Share
Offers a diagnostic grade testing solution with reliable and reproducible results.

Testing of oral fluid specimens is becoming increasingly popular in the workplace, prisons and in drug rehabilitation clinics. Its usefulness as an aid in clinical diagnosis has been acknowledged and as a result there are many testing devices on the market for oral fluid screening.

Unlike rapid tests, Randox Biochip Array Technology offers a diagnostic grade testing solution with reliable and reproducible results.

Biochip arrays offer a one-shot multiplex assay, detecting up to ninety-seven drugs and drug metabolites from an undivided oral fluid sample.

Matrix dedicated kits ensure leading assay performance and excellent specificity, even at lower drug concentrations.

Randox biochip arrays meet the limit of detection requirements for both the European Workplace Drug Testing Society guidelines for oral fluid testing (2010) and the Australian and New Zealand procedures for specimen collection and the detection and quantification of drugs in oral fluid AS 4760-2006 (2006).

The highly efficient Biochip arrays also provide a rapid turn around time, which is advantageous for onsite workplace drug testing. In comparison, a four-plate automated ELISA system would require thirteen times longer to process the same results.

Randox recently launched a point of collection biochip analyzer; the ‘Evidence MultiStat’ which processes multiple results in less than twenty minutes.

The Biochip platform is multi-matrix, therefore a number of sample types including oral fluid, whole blood, urine and post-mortem tissue can be run on the system.

The Randox line of Evidence immunoassay analyzers generate quality control data automatically with every run, ensuring that each test has been carried out successfully.

With a number of benefits to be gained from onsite testing, oral fluid will continue to be put into practice for drugs of abuse screening.

As the prevalence of designer drugs and new variations of drugs enter the market, workplace drug testing is set to increase in a bid to detect and deter use.

Corporations considering Workplace Drug Testing should seek to implement a drug policy and screening program in accordance with their National guidelines.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rapid Diagnosis of Myocardial Infarction within Six Hours
Randox develops a multi marker Cardiac biochip array for rapid diagnosis of myocardial infarction and identification of at risk acute coronary syndrome patients.
Wednesday, April 08, 2009
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Device May Detect Urinary Tract Infections Faster
A Lab-on-a-Disc platform developed by a German and Irish team of researchers dramatically cut the time to detect bacterial species that cause urinary tract infections -- a major cause of sepsis.
Automation Abound at AACC in Atlanta
Discover the latest breakthroughs, trends and products from the AACC Annual Meeting & Clinical Lab Expo.
Real-Time Data for Cancer Therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!